Loading clinical trials...
Loading clinical trials...
Multi-Center, Randomized, Double-Blind, Repeated Doses Study to Evaluate the Safety, Tolerability and Pharmacodynamic Activity of Inhaled TPI-1020 Versus Inhaled Budesonide in Smokers With Mild Reversible Asthma
Conditions
Interventions
TPI-1020
budesonide
Locations
7
Canada
McMaster University Hospital
Hamilton, Ontario, Canada
Kingston General Hospital
Kingston, Ontario, Canada
CARL
Laval, Quebec, Canada
Montreal Chest Institute
Montreal, Quebec, Canada
Hopital Sacre Coeur
Montreal, Quebec, Canada
Centre Hospitalier St-Sacrement
Ste-Foy, Quebec, Canada
Start Date
May 1, 2006
Primary Completion Date
March 1, 2007
Completion Date
March 1, 2007
Last Updated
December 3, 2012
NCT07486401
NCT02327897
NCT07219173
NCT04706988
NCT04639791
NCT06471257
Lead Sponsor
Syntara
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions